Godavari Drugs

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
98.11
-3.95 (-3.87%)
BSENSE

Jan 19

BSE+NSE Vol: 10.52 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024

Compare Profit and Loss Results of Godavari Drugs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
113.00
285.00
-172.00
-60.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
113.00
285.00
-172.00
-60.35%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-2.00
-1.00
-50.00%
Raw Materials Consumed
85.00
269.00
-184.00
-68.40%
Power & Fuel Cost
6.00
1.00
5.00
500.00%
Employee Cost
5.00
2.00
3.00
150.00%
Operating Expenses
3.00
2.00
1.00
50.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
0.00
3.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
101.00
275.00
-174.00
-63.27%
Operating Profit (PBDIT) excl Other Income
11.00
10.00
1.00
10.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
12.00
11.00
1.00
9.09%
Interest
4.00
0.00
4.00
0%
Profit before Depriciation and Tax
8.00
10.00
-2.00
-20.00%
Depreciation
2.00
0.00
2.00
0%
Profit Before Taxation & Exceptional Items
5.00
9.00
-4.00
-44.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
9.00
-4.00
-44.44%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
4.00
7.00
-3.00
-42.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
61.00
-41.00
-67.21%
Profit Available for appropriations
24.00
69.00
-45.00
-65.22%
Appropriations
24.00
69.00
-45.00
-65.22%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
5.82
23.02
-17.20
-74.72%
Profit And Loss - Net Sales
Net Sales 113.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024

Profit And Loss - Interest
Interest 4.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024